Vaccines reduce the risk of developing COVID-19 — but studies disagree on their protective effect against long COVID. Authors: Heidi Ledford Physiotherapist David Putrino’s neurological rehabilitation clinics used to treat […]
New Study Shows Insomnia More Common in COVID-19 Survivors
Authors: Sarah Shoen Updated October 27, 2021 Home / Sleep News / New Study Shows Insomnia More Common in COVID-19 Survivors COVID-19 infection may have a large neurological and psychiatric impact on as many […]
6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records
Authors: Maxime Taquet, John R Geddes, Masud Husain, Sierra Luciano, Paul J Harrison Summary Background Neurological and psychiatric sequelae of COVID-19 have been reported, but more data are needed to […]
What do we know about covid vaccines and preventing transmission?
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o298 (Published 04 February 2022) Cite as: BMJ 2022;376:o298 Authors: Chris Stokel-Walker, Vaccines that work against SARS-CoV-2 have helped change the course of the pandemic by reducing illness and hospital admissions. […]
Sleep disorders and COVID-19
Authors: Sushanth Bhata,∗ and Sudhansu Chokrovertyb Sleep Med. 2021 Jul 18doi: 10.1016/j.sleep.2021.07.021 Abstract This chapter summarizes the known associations between COVID-19 and sleep dysfunction, including insomnia, excessive daytime sleepiness, restless legs syndrome and nightmares, […]
COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies
Authors: Eleonora Calabretta, 1 , 12 Jose M. Moraleda, 2 Massimo Iacobelli, 3 Ruben Jara, 4 Israel Vlodavsky, 5 Peter O’Gorman, 6 Antonio Pagliuca, 7 Clifton Mo, 8 Rebecca M. Baron, 9 Alessio Aghemo, 10 , 12 Robert Soiffer, 8 Jawed Fareed, 11 Carmelo Carlo‐Stella, 1 , 12 , * and Paul Richardson 8 , * Br J Haematol. 2021 Apr; 193(1): 43–51.Published online […]
Ophthalmic Manifestations Of Coronavirus (COVID-19)
Authors: Katherine Hu; Jay Patel; Cole Swiston; Bhupendra C. Patel. January 8, 2022. Introduction Since December 2019, coronavirus disease 2019 (COVID-19) has become a global pandemic caused by the highly transmissible severe acute […]
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Authors: Toshiaki Iba 1, Jean Marie Connors 2, Jerrold H Levy 3 PMID: 32918567 PMCID: PMC7486586 DOI: 10.1007/s00011-020-01401-6 Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the elevated D-dimer without remarkable changes of other global coagulation markers is associated […]
COVID-19-associated coagulopathy: An exploration of mechanisms
Authors: Meaghan E Colling 1, Yogendra Kanthi 2 PMID: 32558620 PMCID: PMC7306998 OI: 10.1177/1358863X20932640 Abstract An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to the virus SARS-CoV-2, has infected millions of people and […]
Role of von Willebrand Factor in COVID-19 Associated Coagulopathy
Authors: Zhen W Mei, Xander M R van Wijk, Huy P Pham, Maximo J Marin The Journal of Applied Laboratory Medicine, Volume 6, Issue 5, September 2021, Pages 1305–1315, https://doi.org/10.1093/jalm/jfab042Published: 13 June 2021 Abstract […]